A recent study confirms the stability of XSB-001 biosimilar for retinal diseases under realistic clinical handling conditions ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback